Cytomab 100 mg Injection
80,89$
63,10$
Cytomab 100 mg Injection is a targeted monoclonal antibody therapy designed to address a range of immune-related disorders, primarily focusing on specific types of cancer such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia. By selectively binding to cancerous cells, Cytomab enhances the body's immune response, effectively inhibiting tumor growth and promoting cell death in affected tissues. This innovative treatment option is particularly beneficial for patients who have not responded well to traditional therapies, providing a new avenue for hope. However, it is essential to be aware of potential side effects, including an increased risk of infections and infusion reactions, which may require close monitoring during administration. As with any medication, discussing your medical history and current health status with your healthcare provider before starting Cytomab is crucial to ensure optimal safety and efficacy. With its unique mechanism of action and targeted approach, Cytomab represents a significant advancement in cancer treatment, helping to improve patient outcomes. Always consult with a healthcare professional to understand the benefits and risks associated with this therapy.
Quantité
Active Pharmaceutical Ingredient
Uses
• Cytomab 100 mg injection is commonly used in the treatment of non-Hodgkin lymphoma (NHL). This type of cancer affects the lymphatic system and can vary in severity. Cytomab works by targeting specific cells involved in the cancer process, helping to manage the disease. Patients receiving this treatment may experience a reduction in tumor size and improved overall health.
• In cases of rheumatoid arthritis, Cytomab 100 mg injection serves as an effective therapeutic option. This autoimmune condition leads to chronic inflammation and joint damage. By administering Cytomab, healthcare providers aim to reduce inflammation and slow disease progression. Many patients find relief from symptoms and improved joint function with this treatment.
• Cytomab 100 mg injection is also indicated for patients with chronic lymphocytic leukemia (CLL), a type of blood cancer. This medication helps to target and eliminate abnormal lymphocytes, which are responsible for the disease. By incorporating Cytomab into the treatment plan, healthcare professionals can enhance the patient's quality of life. This approach may lead to better management of the condition and prolonged survival rates.
• Additionally, Cytomab 100 mg injection is utilized in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis. These conditions are characterized by inflammation of blood vessels, leading to various complications. Cytomab helps to suppress the inappropriate immune response associated with these diseases. Patients often experience a significant reduction in symptoms and improved organ function as a result of this targeted therapy.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Cytomab 100 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician.
Rheumatoid arthritis: Cytomab 100 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician.
Blood cancer (chronic lymphocytic leukemia): Leukemia, also known as blood cancer, is a malignant neoplasm of the hematopoietic tissues that impairs the body's ability to combat infection. Cytomab 100 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment.
Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Cytomab 100 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA.
Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Cytomab 100 mg Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Cytomab 100 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Cytomab 100 Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Cytomab 100 mg. Please consult your doctor.
• Kidney: Cytomab 100 mg Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Cytomab 100 mg Injection is likely to be safe to use while breastfeeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Cytomab 100 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Cytomab 100 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Cytomab 100 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.